Goa-based Molbio Diagnostics has announced its partnership with Finnish innovation leader, Testi Technologies, to manufacture its flagship product PROMILLESS - a saliva-based diagnostics test to measure body alcohol content.

According to the World Health Organization, alcohol consumption contributes to 3 million deaths each year globally as well as to the disabilities and poor health of millions of people. The harmful use of alcohol is responsible for 5.1% of the global burden of disease. 

PROMILLESS, an easy to use, low cost, saliva based self-diagnostics test that has been developed together with VTT (Technical Research Centre of Finland), is a CE approved class 1 device that is patented worldwide. 

The self-test alcohol strip recognises alcohol content from saliva and determines if the alcohol content is above or below the indicated threshold level. T 

Broadening its scope, Testi Technologies is venturing into both human and pet healthcare markets with a forthcoming saliva-based glucose test. 

Under the current agreement, Molbio will have the rights to commercialise, market and sell PROMILLESS under its own brand name globally.

Sriram Natarajan, Chief Executive Officer of Molbio Diagnostics says, “The current test for alcohol, the upcoming test for glucose and many more human and veterinary tests in the pipeline will prove to be revolutionary.”